---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-065214"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2026-05-21T21:00:44+00:00"
generated_at: "2026-05-21T21:07:17.091676+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "low"
source: SEC EDGAR
---

# VYNE and Yarrow publish investor presentation for proposed merger

## Summary
- Yarrow Bioscience published an investor presentation on May 21, 2026, now available on VYNE's website.
- VYNE previously filed Form S-4 (No. 333-294804) with proxy statement/prospectus for the proposed Yarrow acquisition.
- Presentation provides overview of Yarrow's business as part of the pending merger with VYNE.

## SEC filing metadata
- accession: 0001104659-26-065214
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2026-05-21T21:00:44+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465926065214/0001104659-26-065214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465926065214/tm2615387d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-065214
- JSON: https://secwatch.observer/filing/0001104659-26-065214.json
- Plain text: https://secwatch.observer/filing/0001104659-26-065214.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.